Septodont

BioRoot Flow is a bioceramic root canal sealer that is easy to use and provides excellent results. It is made of calcium silicate, which is a biocompatible material that is naturally found in the body. BioRoot Flow has a unique flowable consistency that makes it easy to inject into the root canal, and it provides excellent adhesion to dentin and gutta-percha. BioRoot Flow is also radiopaque, which makes it easy to visualize during the root canal procedure. BioRoot Flow has been shown to be effective in preventing bacterial leakage and promoting the healing of the periapical tissues. It is a safe and effective root canal sealer that can be used in a variety of clinical situations. Features & benefits Easy – Ready-to-use syringe provides easy extrusion directly into canals and you maintain your preferred obturation technique Successful – Highly-pure calcium silicate mineral formulation (resin-free) means no shrinkage, limited bacterial growth, and increased biocompatibility and bioactivity which reduce the risk of adverse reactions For Everyone – Designed for cold and warm techniques with excellent flow into accessory canals, tight adhesion to dentin and gutta-percha, and reproducible results in all root canal treatments from simple to complex Presentation Item #01E0510 - 1 x 2g syringe, 1 finger grip, 20 intra-oral tips BioRoot™ Flow is a pure mineral calcium silicate root canal sealer, available in premixed 2g syringe for both cold and warm obturation. Item Description: BioRoot™ Flow, (1) 2g syringe, (1) Finger Grip, (20) Replaceable Tips/box (24 Month Shelf Life) (For Sale in the U.S. Only) Supplier Item Code: 01E0510 NDC Item Code: SEP 01E0510 Unit of Measure: BX WEIGHT (POUNDS): 0.1400

Read more less

OraVerse Local Anesthesia Reversal Agent. Box containing 1 blister of 10 x 1.7 OraVerse is the first and only local anesthesia reversal agent In clinical trials, the median time to recovery of normal sensation in the upper lip was 50 minutes for OraVerse patients vs. 133 minutes for the control group and in the lower lip was 70 minutes for OraVerse patients vs. 155 minutes for the control. In clinical trials, OraVerse patients were more quickly able to smile, speak, drink normally and minimize drooling. Market research shows 88% of patients may be interested in receiving a product like OraVerse1 Presentation Item #99210 – Box containing 1 blister of 10 x 1.7ml glass cartridges

Read more less